We downgrade our rating from UNDERPERFORM to SELL as FRT’s share price has rallied ~17% over the last three months. Meanwhile, we keep our target price (TP) unchanged as an upward revision to our projections of Long Chau’s (pharmacy chain) profitability — which is mainly thanks to lower opex — offsets weaker profit projections for the mobile business.